Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1991 1
1993 1
1994 2
1997 5
1998 1
1999 4
2000 2
2001 4
2002 8
2003 4
2004 1
2005 3
2006 6
2007 3
2008 3
2009 5
2010 6
2011 7
2012 3
2013 5
2014 7
2015 5
2016 4
2017 7
2018 8
2019 12
2020 11
2021 16
2022 10
2023 6
2024 8
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for palacios f
Search for Palacio SF instead (1 results)
Parasitic infectious diseases.
Palacios F, Alonso C. Palacios F, et al. Eur J Med Chem. 2020 May 1;193:112230. doi: 10.1016/j.ejmech.2020.112230. Epub 2020 Mar 10. Eur J Med Chem. 2020. PMID: 32199133 No abstract available.
Fused 1,5-Naphthyridines: Synthetic Tools and Applications.
Masdeu C, Fuertes M, Martin-Encinas E, Selas A, Rubiales G, Palacios F, Alonso C. Masdeu C, et al. Among authors: palacios f. Molecules. 2020 Jul 31;25(15):3508. doi: 10.3390/molecules25153508. Molecules. 2020. PMID: 32752070 Free PMC article. Review.
Medical Treatment for Postthrombotic Syndrome.
Palacios FS, Rathbun SW. Palacios FS, et al. Semin Intervent Radiol. 2017 Mar;34(1):61-67. doi: 10.1055/s-0036-1597765. Semin Intervent Radiol. 2017. PMID: 28265131 Free PMC article. Review.
Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial.
Szarvas Z, Reyff ZA, Peterfi A, Pinto CB, Owens CD, Kaposzta Z, Mukli P, Pinaffi-Langley ACDC, Adams CA, Muranyi M, Palacios FS, Hawkins B, Baur JA, Velez FS, Prodan CI, Kirkpatrick AC, Csiszar A, Ungvari Z, Balasubramanian P, Negri S, Tarantini S, Ding K, Buelow AA, Akbari A, Kellawan JM, Yabluchanskiy A. Szarvas Z, et al. Among authors: palacios fs. J Pharmacol Exp Ther. 2025 Jul;392(7):103607. doi: 10.1016/j.jpet.2025.103607. Epub 2025 May 14. J Pharmacol Exp Ther. 2025. PMID: 40479886 Clinical Trial.
A patent review of topoisomerase I inhibitors (2016-present).
Selas A, Martin-Encinas E, Fuertes M, Masdeu C, Rubiales G, Palacios F, Alonso C. Selas A, et al. Among authors: palacios f. Expert Opin Ther Pat. 2021 Jun;31(6):473-508. doi: 10.1080/13543776.2021.1879051. Epub 2021 Apr 29. Expert Opin Ther Pat. 2021. PMID: 33475439 Review.
Targeting S100A9-mediated inflammation: A novel therapeutic approach for CLL.
Uriepero-Palma A, Marquez ME Dr, Payque E, Mediavilla-Varela M, Gamal W, Maharaj K, Powers JJ, Eksioglu EA, Chavez JC, Sernbo S, Palacios F, Querol Rivas J, Ortega C, Uria R, Dos Santos G, Oliver C, Landoni AI Dra, Sahakian E, Oppezzo P, Pinilla-Ibarz J. Uriepero-Palma A, et al. Among authors: palacios f. Blood Adv. 2025 Jul 28:bloodadvances.2025016061. doi: 10.1182/bloodadvances.2025016061. Online ahead of print. Blood Adv. 2025. PMID: 40720748
Phosphinotripeptidic Inhibitors of Leucylaminopeptidases.
Jewgiński M, Haremza K, de Los Santos JM, Es Sbai Z, Oszywa B, Pawełczak M, Palacios F, Latajka R. Jewgiński M, et al. Among authors: palacios f. Int J Mol Sci. 2021 May 11;22(10):5090. doi: 10.3390/ijms22105090. Int J Mol Sci. 2021. PMID: 34065004 Free PMC article.
159 results